Search - tctmd.com

Displaying 221 - 240 of 248

Sort: Relevancy | Date

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Jason Kahn

October 11, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Daily News

Una Revisión de JAMA Aborda las Complejidades del Tratamiento Médico tras una PCI

Caitlin E. Cox

July 11, 2013

News Daily News

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Caitlin E. Cox

July 11, 2013

Presentation EuroPCR 2013

The Unplanned DAPT Discontinuation Patient: How Can I Make Informed Decisions?

Presenter: Sigmund Silber

May 22, 2013

Presentation

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Presenter: K. Tandjung

April 26, 2013

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

Presentation

RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Presenter: B-K Kim

September 19, 2012

News Conference News ESC 2012

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Yael L. Maxwell

August 28, 2012

Presentation ACC 2012

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Presenter: Myeong-Ki Hong

March 25, 2012

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Nuevo Análisis PLATO: Las dosis de Aspirina podrían Explicar los Resultados Discordantes de Norteamérica

Caitlin E. Cox

March 06, 2012

News Daily News

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Caitlin E. Cox

March 06, 2012

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

Advertisement

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Una Revisión de JAMA Aborda las Complejidades del Tratamiento Médico tras una PCI

JAMA Review Tackles Intricacies of Medical Therapy After PCI

The Unplanned DAPT Discontinuation Patient: How Can I Make Informed Decisions?

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Nuevo Análisis PLATO: Las dosis de Aspirina podrían Explicar los Resultados Discordantes de Norteamérica

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Six Months Sufficient for Dual Antiplatelet Therapy

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content